Welcome to Rhineland-Palatinate and Mainz – 
a hub for biotechnology and life sciences!

Benefits and prospects for the region:

  • > 500

    research projects with a biotech focus are currently underway across the state.

  • 13,6

    patents per million inhabitants, making Rhineland-Palatinate Germany's foremost centre of scientific innovation.

  • TOP 3

    worldwide: Mainz is ranked among the top global locations in the field of mRNA-based vaccines.

  • > 55 k

    employs the biotechnology sector in Rhineland-Palatinate – and rising.

A new promotional video by the state and the city of Mainz focuses on these and other aspects while highlighting the benefits and prospects the region offers companies, start-ups and people involved in scientific research. 

Today, the German state of Rhineland-Palatinate and its capital, Mainz, have established themselves as a leading hub for research, science and business that boasts a wealth of expertise. This is where fundamental research makes the transition into real-world applications. 

Alongside a number of leading global players and centres of scientific excellence as well as a high level of AI proficiency, there is also a thriving start-up ecosystem throughout the state that is constantly working to shape a better future with creativity and an enterprising mindset.

This region already provides students, researchers, entrepreneurs and companies from across the world with the optimum environment to achieve their goals. It is a place where you can make a real difference to people's lives - and enjoy a fulfilling life yourself. 

The city and the state are committed to improving these positive factors even further and to ensuring that this region continues to evolve into an even more successful global hub for biotechnology and life sciences. 

For the challenges of tomorrow’s demands!